DMAC · ISSUER CIK 1401040
DiaMedica Therapeutics Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 DiaMedica Therapeutics Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 12, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 202616:23 | Aug 10, 2026 | DMAC | President & CEO, Director | A · Grant | — | +60,200 | 128,791 | +88% | — |